Team:Paris Bettencourt/Achievements
From 2012.igem.org
(→Achievements of all the different modules) |
|||
Line 84: | Line 84: | ||
</tr> | </tr> | ||
</table> | </table> | ||
+ | |||
<table id="tableboxed"> | <table id="tableboxed"> | ||
Line 198: | Line 199: | ||
#'''''We screened previous iGEM team’s wikis''''' to trace the evolution of biosafety concerns and devices in the iGEM community, focusing on proposed containment systems. [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/WikiScreen Read More] | #'''''We screened previous iGEM team’s wikis''''' to trace the evolution of biosafety concerns and devices in the iGEM community, focusing on proposed containment systems. [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/WikiScreen Read More] | ||
#'''''We focused on horizontal gene transfer as main generic risk factor'''''. | #'''''We focused on horizontal gene transfer as main generic risk factor'''''. | ||
- | #'''''Synthetic report''''' where we addressed the concerns raised by synthetic biology per se, that is, as a technique. Then, we analyzed the specific concerns that arise from synthetic biology’s potential applications in nature. [https://2012.igem.org/Team: | + | #'''''Synthetic report''''' where we addressed the concerns raised by synthetic biology per se, that is, as a technique. Then, we analyzed the specific concerns that arise from synthetic biology’s potential applications in nature. [https://2012.igem.org/Team:Paris_Bettencou |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 03:17, 27 September 2012
Semantic containment
Aims
System
Achievements :
Both part were well characterized and works well. For the second parts, we show that as expected, one mutation is quite leaky, although it works qualitatively, but one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.
|
Suicide system
Aims : Implement a kill-switch that features population-level suicide and complete genome degradation. System : A synthetic toxin-anti-toxin system based on the wild type Colicin E2 operon. Achievements : We showed that Colicin E2 cells induce cell death in sensitive populations, and that these sensitive populations can be protected by providing them with our engineered immunity protein.
Part K914001 is well characterized and provides immunity to sensitive cells against the Colicin E2 activity protein, but is leaky. Part K914002 is promoterless and allows users to easily plug in the appropriate promoter for their desired purpose.
|
Restriction Enzyme System
To design a plasmid self-digestion system. Experimental System: We are testing different combinations of promoters and restriction enzymes. We have to characterize both the promoters (by measuring the expression of RFP) and the restriction enzymes (by measuring killed cells). Achievements :
|
Delay System
Aim : A programmed delay will allow the cell to perform its intended function before our DNA-degrading suicide machinery is expressed. Experimental system: We used two different approaches to create this delay. The first one is based on the gradual dilution of a regulatory transcription factor. The second one makes use of a stationary-phase specific promoter. Both systems eventually result in the expression of the restriction enzyme I-SceI. In the final design, I-SceI cleaves the antitoxin gene, ultimately dooming the cell. Each step in this causal sequence contributes to the overall delay in the system.
|
MAGE
Aims : Removal of four FseI restriction sites from E. coli MG1655 genome. Experimental System: Using multiplex automated genome engineering (MAGE) - a technique capable of editing the genome by making small changes in existing genomic sequences. Achievements: Proof of concept by introducing a stop codon in the middle of the lacZ gene |
Synthetic Import Domain
Creation of a novel protein import mechanism in bacteria.
Exploit the natural Colicin import domain fused to any protein at will, dubbed here: "Synthetic Import Domain". Achievements:
|
Encapsulation
Aim: Harness bacteria-containing gel beads to assure cell containment and complement activity of genetic safety systems. Experimental system: Bacterial cells are encapsulated in alginate beads. We used a cell containment assay based on plating to assess the release of cells from alginate beads. In addition, we aimed at improving the entrapment of cells through stabilization by polyethyleneimine and covalent cross-linkage by glutaraldehyde. Achievements:
|
Human Practice
Aim To chart new venues of best practice for synthetic biology. To this end, we examined the ethical, biological and social concerns related to the release of genetically modified bacteria in the wild. Metodology
|